Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction
Top Cited Papers
- 20 February 2015
- journal article
- clinical trial
- Published by Bentham Science Publishers Ltd. in Current Drug Abuse Reviews
- Vol. 7 (3), 157-164
- https://doi.org/10.2174/1874473708666150107121331
Abstract
Psilocybin-occasioned mystical experiences have been linked to persisting effects in healthy volunteers including positive changes in behavior, attitudes, and values, and increases in the personality domain of openness. In an open-label pilot-study of psilocybin-facilitated smoking addiction treatment, 15 smokers received 2 or 3 doses of psilocybin in the context of cognitive behavioral therapy (CBT) for smoking cessation. Twelve of 15 participants (80%) demonstrated biologically verified smoking abstinence at 6-month follow-up. Participants who were abstinent at 6 months (n=12) were compared to participants still smoking at 6 months (n=3) on measures of subjective effects of psilocybin. Abstainers scored significantly higher on a measure of psilocybin-occasioned mystical experience. No significant differences in general intensity of drug effects were found between groups, suggesting that mystical-type subjective effects, rather than overall intensity of drug effects, were responsible for smoking cessation. Nine of 15 participants (60%) met criteria for “complete” mystical experience. Smoking cessation outcomes were significantly correlated with measures of mystical experience on session days, as well as retrospective ratings of personal meaning and spiritual significance of psilocybin sessions. These results suggest a mediating role of mystical experience in psychedelic-facilitated addiction treatment.Keywords
This publication has 50 references indexed in Scilit:
- Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy VolunteersBiological Psychiatry, 2015
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of opennessJournal of Psychopharmacology, 2011
- Mindfulness training for smoking cessation: Results from a randomized controlled trialDrug and Alcohol Dependence, 2011
- The neurobiology of psychedelic drugs: implications for the treatment of mood disordersNature Reviews Neuroscience, 2010
- Neural correlates of reexperiencing, avoidance, and dissociation in PTSD: Symptom dimensions and emotion dysregulation in responses to script‐driven trauma imageryJournal of Traumatic Stress, 2007
- Amygdala, Medial Prefrontal Cortex, and Hippocampal Function in PTSDAnnals of the New York Academy of Sciences, 2006
- Dose-Response Study of N,N-Dimethyltryptamine in HumansArchives of General Psychiatry, 1994
- The Experimental Use of Psychedelic (LSD) PsychotherapyJAMA, 1970
- Reports of Wives of Alcoholics of Effects of LSD-25 Treatment of Their HusbandsArchives of General Psychiatry, 1966
- THE GENERALIZATION OF ‘STUDENT'S’ PROBLEM WHEN SEVERAL DIFFERENT POPULATION VARLANCES ARE INVOLVEDBiometrika, 1947